z-logo
open-access-imgOpen Access
Asciminib (Scemblix)
Author(s) -
CADTH
Publication year - 2022
Publication title -
canadian journal of health technologies
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2022.422
Subject(s) - myeloid leukemia , medicine , tyrosine kinase inhibitor , drug , tyrosine kinase , philadelphia chromosome , oncology , intensive care medicine , family medicine , pharmacology , cancer , genetics , biology , chromosomal translocation , receptor , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here